pharmacopeia
GET
/api/v1/drug/dextran

Mechanism of action

Sourced from openFDA

Mechanism-of-action class: Structural Macromolecules.

Indications

Sourced from openFDA
  • Uses • relieves redness of the eye due to minor eye irritations • as a lubricant to prevent further irritation or to relieve dryness of the eye

Dosage & administration

Sourced from openFDA

Directions Instill 1 to 2 drops in the affected eye(s) up to 4 times daily. Relabeled By: Preferred Pharmaceuticals Inc. NDC 68788-8635-1

Warnings & precautions

Sourced from openFDA

For external use only Ask a doctor before use if you have narrow angle glaucoma Stop use and ask a doctor if you experience • eye pain • changes in vision • continued redness or irritation of the eye, or if the condition worsens or persists for more than 72 hours When using this product • pupils may become enlarged temporarily • to avoid contamination, do not touch tip of container to any surface. Replace cap after using. • if solution changed color or becomes cloudy, do not use • overuse may produce increased redness of the eye • remove contact lens before using If pregnant or breast-feeding , ask a health professional before use. Keep out of reach of children. If swallowed, get medical help or contact a Poison control Center (1-800-111-1222) right away.

Approval history

Sourced from openFDA
  • Apr 29, 1974NDANDA017441Allergan

FAERS reports

View JSON
Reference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. Counts reflect reporting volume — how often a reaction was reported, not how often it occurs. For decision-grade use, consult openFDA and the FAERS Public Dashboard directly.
1,703 total reports matchedLatest report Share = reports listing the reaction ÷ total matched reports. Rows can sum to >100% because a single report often lists multiple reactions.
  1. 1Dyspnoea26516%
  2. 2Infusion Related Reaction1569.2%
  3. 3Nausea1368.0%
  4. 4Back Pain1176.9%
  5. 5Flushing1076.3%
  6. 6Chest Pain1066.2%
  7. 7Anaphylactic Reaction1036.0%
  8. 8Dizziness945.5%
  9. 9Off Label Use935.5%
  10. 10Pruritus885.2%
  11. 11Chest Discomfort804.7%
  12. 12Hypotension764.5%
  13. 13Vomiting744.3%
  14. 14Headache734.3%
  15. 15Diarrhoea714.2%

Literature

View JSON

Recent PubMed references pinned to Dextran as a MeSH major topic. Citations link to pubmed.ncbi.nlm.nih.gov.

Clinical trials

View JSON

The 10 most recently updated of 247 ClinicalTrials.gov registrations naming Dextran as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.

Frequently asked questions

How does Dextran work?
Mechanism-of-action class: Structural Macromolecules.
What is Dextran used for?
According to FDA labeling, Dextran carries indications including: Uses • relieves redness of the eye due to minor eye irritations • as a lubricant to prevent further irritation or to relieve dryness of the eye. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.
What class of drug is Dextran?
Dextran is classified as Blood substitutes and plasma protein fractions, Structural Macromolecules, Increased Intravascular Volume.
Note. Data for dextran is illustrative MVP content compiled from public sources. pharmacopeia is for educational and informational use only and is not a substitute for professional medical advice.

Search pharmacopeia

Search drugs, classes, and ingredients